Metabolon Lands $14,999,980 Series E Funding

  • Feed Type
  • Date
    12/31/2013
  • Company Name
    Metabolon
  • Mailing Address
    617 Davis Dr. Durham, NC 27713 USA
  • Company Description
    Metabolon has quickly become a leader in the discovery of biomarkers using metabolomics. Located in Research Triangle Park, North Carolina, Metabolon is based in a biotechnology epicenter.
  • Website
    http://www.metabolon.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,999,980
  • Transaction Round
    Series E
  • Proceeds Purposes
    Proceeds will support the recent launch by Metabolon’s partner, Bostwick Laboratories, of Prostarix(TM), a urine-based test that provides important metabolic information on the likelihood that a patient with slightly elevated PSA scores has prostate cancer, thus confirming the need to proceed to biopsy. The funds will also be used for the continued development of Quantose(TM) IGT, Metabolon’s surrogate test for oral glucose tolerance, as well as its test for the recurrence of bladder cancer.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy